Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta
单细胞分析确定人胎盘中的保护性和耐受性免疫细胞群
基本信息
- 批准号:10401230
- 负责人:
- 金额:$ 6.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-07 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAgonistAllogenicAntigen PresentationAntigen-Presenting CellsAntigensAutoantigensAutoimmunityBiological AssayBiological MarkersBloodCellsCellular Indexing of Transcriptomes and Epitopes by SequencingCoculture TechniquesColorCytometryDataDeciduaDendritic CellsDiseaseEventExposure toFetusFlow CytometryFluorescenceFutureGene Expression ProfilingGoalsHealthHeterogeneityHumanImmuneImmune responseImmune systemImmunocompetenceImmunologicsInfectionInterventionLinkMaintenanceMaternal ExposureMeasuresMediatingMothersNaturePathologicPathologyPhenotypePlacentaPlayPopulationPopulation HeterogeneityPre-EclampsiaPregnancyProfessional RolePropertyProteinsReproductionRoleSystemT-Cell ActivationT-LymphocyteT-Lymphocyte SubsetsTestingTimeTissuesTransplantationUmbilical Cord BloodUterusadaptive immune responseadverse pregnancy outcomebasechemokinecytokinedesignearly pregnancyembryo/fetus antigenexhaustionexperimental studyfetalfightinghigh dimensionalityimprovedinsightinter-individual variationmouse modeloffspringpregnancy disorderpreventreceptorreproductivereproductive outcomeresponsesingle cell analysistherapeutic targettranscriptome
项目摘要
Maternal immune adaptation to pregnancy requires maintenance of immune competence with concurrent
specific tolerance of the semi-allogeneic fetus. Immune maladaptation has been associated with several
adverse pregnancy outcomes, with both short- and long-term impact on maternal and offspring health.
Maternal exposure to fetal-placental antigens during pregnancy is well-established; however, many questions
remain about the nature of both antigen presentation and the resultant adaptive immune response. Eliciting a
de novo adaptive immune response requires the activation of professional antigen presenting cells (APCs),
especially dendritic cells (DCs). Importantly, DCs can also induce T cell tolerance and thus play a critical role in avoiding unwanted immune responses. This has been typically studied in the context of preventing responses against self-antigens and is also relevant for protection of the fetus from maternal rejection. It remains unknown how APCs in the human placenta and decidua provide protection against infection and at the same time prevent immune responses against the fetus. A major roadblock to understanding protection and tolerance in human reproduction is the limited information about the functional profile of these APCs, and their inter-individual variation. We propose to define human APC subsets in maternal blood, placenta, decidua, and umbilical cord blood to test the hypothesis that APCs involved in human reproduction consist of several subsets that are functionally specialized to contribute to either protection or tolerance. To accomplish this, we will take advantage of recent technological advances in the field of single-cell analysis, namely high-
dimensional cytometry and single-cell gene expression analysis to dissect the functional heterogeneity within
this immune compartment. Our lab has developed and validated multiple 28-color fluorescence cytometry
assays, which interrogate cell phenotype, activation, and functional capacity (i.e. expression of exhaustion
markers, inhibitory receptors, co-stimulatory molecules). We will employ these assays to determine the
composition and capabilities of cells directly ex vivo. These experiments will provide critical insight to define
functional specialization of DCs in healthy human reproductive tissues during pregnancy and also provide the
basis to study pathologies such as preeclampsia in the future.
母体对妊娠的免疫适应需要维持免疫能力,
半同种异体胎儿的特异性耐受。免疫适应不良与几种
不利的妊娠结果,对产妇和后代的健康产生短期和长期影响。
孕妇在怀孕期间暴露于胎儿-胎盘抗原是公认的;然而,许多问题
关于抗原呈递和由此产生的适应性免疫应答的性质仍然存在争议。们逗得哈哈
从头适应性免疫应答需要专职抗原呈递细胞(APC)的活化,
特别是树突状细胞(DC)。重要的是,DC还可以诱导T细胞耐受,从而在避免不必要的免疫应答中发挥关键作用。这通常是在预防对自身抗原的反应的背景下研究的,也与保护胎儿免受母体排斥有关。目前尚不清楚人类胎盘和蜕膜中的APC如何提供抗感染的保护,同时防止对胎儿的免疫反应。理解人类生殖中的保护和耐受的一个主要障碍是关于这些APC的功能概况及其个体间变异的有限信息。我们建议在母血、胎盘、蜕膜和脐带血中定义人APC亚群,以检验以下假设:参与人类生殖的APC由几个亚群组成,这些亚群在功能上专门用于保护或耐受。为了实现这一点,我们将利用单细胞分析领域的最新技术进步,即高-
三维细胞术和单细胞基因表达分析,以剖析功能异质性内
这个免疫区。我们的实验室已经开发并验证了多重28色荧光细胞仪
分析,其询问细胞表型、活化和功能能力(即耗竭的表达)
标记物、抑制性受体、共刺激分子)。我们将使用这些检测来确定
细胞的组成和能力直接离体。这些实验将提供关键的洞察力,
在妊娠期间,DC在健康人类生殖组织中的功能特化,并且还提供了
为将来研究先兆子痫等病理学奠定了基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin Prlic其他文献
Martin Prlic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin Prlic', 18)}}的其他基金
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta
单细胞分析确定人胎盘中的保护性和耐受性免疫细胞群
- 批准号:
9978484 - 财政年份:2020
- 资助金额:
$ 6.39万 - 项目类别:
Single-Cell Analysis To Define Protective and Tolerizing Immune Cell Populations in the Human Placenta
单细胞分析确定人胎盘中的保护性和耐受性免疫细胞群
- 批准号:
10594099 - 财政年份:2020
- 资助金额:
$ 6.39万 - 项目类别:
Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity
炎症驱动的 T 细胞反应及其对宿主免疫的二分效应
- 批准号:
10593467 - 财政年份:2016
- 资助金额:
$ 6.39万 - 项目类别:
Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity
炎症驱动的 T 细胞反应及其对宿主免疫的二分效应
- 批准号:
10058804 - 财政年份:2016
- 资助金额:
$ 6.39万 - 项目类别:
Inflammation-driven T Cell Responses and their Dichotomous Effect on Host Immunity
炎症驱动的 T 细胞反应及其对宿主免疫的二分效应
- 批准号:
10682491 - 财政年份:2016
- 资助金额:
$ 6.39万 - 项目类别:
Paving the Way for a Novel Therapeutic Approach to Combat HIV
为对抗艾滋病毒的新治疗方法铺平道路
- 批准号:
8358310 - 财政年份:2012
- 资助金额:
$ 6.39万 - 项目类别:
CD8 Tau cell contraction and memory formation
CD8 Tau细胞收缩和记忆形成
- 批准号:
7660600 - 财政年份:2009
- 资助金额:
$ 6.39万 - 项目类别:
CD8 Tau cell contraction and memory formation
CD8 Tau细胞收缩和记忆形成
- 批准号:
8282722 - 财政年份:2009
- 资助金额:
$ 6.39万 - 项目类别:
CD8 Tau cell contraction and memory formation
CD8 Tau细胞收缩和记忆形成
- 批准号:
8210398 - 财政年份:2009
- 资助金额:
$ 6.39万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 6.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 6.39万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 6.39万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 6.39万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 6.39万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 6.39万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 6.39万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 6.39万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 6.39万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 6.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




